Global Pricing & Reimbursement
9th February - 11th February 2010 | UK
Category: Commercial
Address: The Bentley Waldorf Hotel, London, UK
Organiser: Informa Life Sciences
Website: CLICK HERE to open
Pricing pharmaceutical products correctly and gaining maximum reimbursement is essential to substantially increase profit margins of pharma and biotech companies. However, without an effective long term strategy on pricing and reimbursement to maximise profit and maintain market share, organisations will suffer and only the most successful will win.
At this event you will:
- Discover how NICE operates within the UK National Health Service: what processes and methods are used for technology appraisals?
- Understand the pricing and reimbursement landscape in Italy: what strategies have been adopted to contain costs and what is the structure of the 21 local health systems?
- Gain market access in Japan: understand the current and future developments and the implications for the global pharma market
- Benefit from first-hand experiences from Novo Nordisk A/S on gaining HTA approval for Type 2 Diabetes drugs in Germany, France, UK, Scotland, The Netherlands, Sweden, Spain and Canada
- Discover market access strategies for oncology drugs: maximise the chance of your drug gaining positive payer decisions
- Assess the impact of pricing & reimbursement on the time-to-market of generic drugs in Romania and other CEE countries
- Participate in interactive panel discussion: Share your opinions and get answers to your questions
